Related references
Note: Only part of the references are listed.Neuroinflammation-Associated Aspecific Manipulation of Mouse Predator Fear by Toxoplasma gondii
Madlaina Boillat et al.
CELL REPORTS (2020)
Large-scale study of Toxoplasma and Cytomegalovirus shows an association between infection and serious psychiatric disorders
Kristoffer Solvsten Burgdorf et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Guanabenz Reverses a Key Behavioral Change Caused by Latent Toxoplasmosis in Mice by Reducing Neuroinflammation
Jennifer Martynowicz et al.
MBIO (2019)
HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice
Taewoo Kim et al.
EXPERIMENTAL NEUROBIOLOGY (2019)
2018 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 36th Annual Report
David D. Gummin et al.
CLINICAL TOXICOLOGY (2019)
Biological evaluation of newly synthesized quinoline-based compound PPQ-8 in acute and chronic toxoplasmosis: An experimental study
Hanan Abd Elgawad et al.
EXPERIMENTAL PARASITOLOGY (2019)
Randomized controlled trial of adjunctive Valproate for cognitive remediation in early course schizophrenia
Ibtihal Ibrahim et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
Toxoplasmosis: A pathway to neuropsychiatric disorders
Shiraz Tyebji et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Calcium signaling and the lytic cycle of the Apicomplexan parasite Toxoplasma gondii
Miryam Andrea Hortua Triana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review
Mahbobeh Montazeri et al.
PARASITOLOGY RESEARCH (2018)
Contribution of Dopamine Neurotransmission in Proconvulsant Effect of Toxoplasma gondii Infection in Male Mice
Jalal Babaie et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Is Toxoplasma gondii a Trigger of Bipolar Disorder?
Claudia Del Grande et al.
PATHOGENS (2017)
Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity
Madalyn M. McFarland et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Novel Approaches Reveal that Toxoplasma gondii Bradyzoites within Tissue Cysts Are Dynamic and Replicating Entities In Vivo
Elizabeth Watts et al.
MBIO (2015)
Valproic Acid Alleviates Memory Deficits and Attenuates Amyloid-β Deposition in Transgenic Mouse Model of Alzheimer's Disease
Ai-Guo Xuan et al.
MOLECULAR NEUROBIOLOGY (2015)
Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate
Guillaume Fond et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2014)
Calcium Entry in Toxoplasma gondii and Its Enhancing Effect of Invasion-linked Traits
Douglas A. Pace et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Cell division in apicomplexan parasites
Maria E. Francia et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe
M. Cornago et al.
CELL DEATH & DISEASE (2014)
Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?
Joanne P. Webster et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2013)
Toxoplasma gondii Actively Inhibits Neuronal Function in Chronically Infected Mice
Fahad Haroon et al.
PLOS ONE (2012)
A review on human toxoplasmosis
Geita Saadatnia et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2012)
Toxoplasma gondii and Other Risk Factors for Schizophrenia: An Update
E. Fuller Torrey et al.
SCHIZOPHRENIA BULLETIN (2012)
Evaluation of Five Antischizophrenic Agents Against Toxoplasma gondii in Human Cell Cultures
David G. Goodwin et al.
JOURNAL OF PARASITOLOGY (2011)
Identification of Intracellular and Plasma Membrane Calcium Channel Homologues in Pathogenic Parasites
David L. Prole et al.
PLOS ONE (2011)
Differential modulation of intracellular Ca2+ responses in B lymphoblasts by mood stabilizers
Tatiana Perova et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Histone Deacetylase Inhibitors Suppress the Expression of Inflammatory and Innate Immune Response Genes in Human Microglia and Astrocytes
Hyeon-Sook Sub et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
The cell cycle and Toxoplasma gondii cell division: Tightly knit or loosely stitched?
Marc-Jan Gubbels et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2008)
Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection
Gretchen Hermes et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice
David G. Goodwin et al.
JOURNAL OF PARASITOLOGY (2008)
Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro
Jeannine S. Strobl et al.
JOURNAL OF PARASITOLOGY (2007)
Histone mediated gene activation in Toxoplasma gondii
William J. Sullivan et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2006)
Comparative genomic and phylogenetic analyses of calcium ATPases and calcium-regulated proteins in the apicomplexa
Kisaburo Nagamune et al.
MOLECULAR BIOLOGY AND EVOLUTION (2006)
Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2
Bjoern Schwer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Actions of a histone deacetylase inhibitor NSC3852 (5-nitroso-8-quinolinol) link reactive oxygen species to cell differentiation and apoptosis in MCF-7 human mammary tumor cells
A Martirosyan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Parasites as causative agents of human affective disorders?: The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour
JP Webster et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2006)
Dynamics of Toxoplasma gondii differentiation
F Dzierszinski et al.
EUKARYOTIC CELL (2004)
Toxoplasma gondii and schizophrenia
EF Torrey et al.
EMERGING INFECTIOUS DISEASES (2003)
Pharmacological and therapeutic properties of valproate - A summary after 35 years of clinical experience
E Perucca
CNS DRUGS (2002)
Share Paper
